Disciplines: Respiratory Therapy
Hours: 3 Contact Hours
Author(s): Eileen S. O'Neill, PhD, RN
Peer Reviewer(s): Vanna M. Dest, MSN, APRN, BC, AOCN
Item#: V7171
Contents: 1 Course Book (50 pages)

Lung Cancer, 2nd Edition

Price $29.95
Item # V7171
When available, the Online Course format is included with the hard copy, eBook, or audio book formats!

Lung cancer is the second most common cancer in both men and women (not including skin cancer), but is the leading cause of cancer deaths in both men and women in the United Sates. (American Cancer Society [ACS], 2014a).

Although several risk factors can contribute to the development of lung cancer. smoking tobacco products – even low tar, menthol or “light” cigarettes – remains the primary risk factor, and causes an estimated 80% of lung cancer deaths; cigar and pipe smokers have almost as high a risk for developing lung cancer as do cigarette smokers (ACS, 2014b). Currently, controlling such risk factors as cigarette smoking and detecting primary tumors early are the most effective ways of reducing mortality rates. Lung cancer research continues to focus on prevention, early screening methods, and more effective targeted treatments to improve outcomes and decrease the adverse effects of current treatments. All patients with lung cancer require ongoing long-term treatment, education about self-care measures, and psychosocial support. This course presents an overview of lung cancer and updated information for healthcare professionals who work with people at risk for or those diagnosed with lung cancer. In addition, because lung cancer can be a chronic illness, there are many lung cancer survivors who continue to need health care. Rapid changes in cancer care make it imperative to have current information about prevention, detection, diagnosis, and treatment. Oncology-related resources for patients, families, and clinicians are also included in the course.

Course Objectives 
  • Describe the epidemiological trends for lung cancer in the United States.
  • Identify risk factors associated with lung cancer development.
  • Discuss measures to prevent lung cancer.
  • Describe the development and clinical manifestations of lung cancer.
  • Describe components of the diagnostic evaluation for lung cancer.
  • Discuss the current treatment options for no-small cell and small cell lung cancer.
  • Describe management strategies to alleviate the common symptoms of lung cancer.
  • Identify measures to provide psychosocial support to the patient and family.
Eileen S. O’Neill, PhD, RN, is a professor emeritus at the College of Nursing at the University of Massachusetts, Dartmouth. Her areas of expertise are pathophysiology, advanced practice nursing, and nursing inquiry. Her clinical practice area is care of the adult patient. Dr. O’Neill’s research program focuses on clinical and patient decision making, including the role of technology in improving patient care. She has been published in several leading nursing journals and is the author of many respiratory-related Western Schools course books.
Vanna M. Dest, MSN, APRN, BC, AOCN, is a nurse practitioner at the CT Healing Center in Hamden, CT. Previously Ms. Dest worked for 28 years as an oncology APRN at the Hospital of Saint Raphael in New Haven, CT. Ms. Dest received her bachelor’s degree from Southern Connecticut State University in 1984, earned her master’s degree from Yale University, New Haven, in 1992, and earned a post-master’s certificate from Yale University in 2002.
  • Contact hours will be awarded for up to one (1) year from the date the course is ordered, unless otherwise indicated with an expiration date.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.